citalopram has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.45) | 18.7374 |
| 1990's | 5 (16.13) | 18.2507 |
| 2000's | 13 (41.94) | 29.6817 |
| 2010's | 10 (32.26) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Daniel, R; Brust, P; Deuther-Conrad, W; Mishani, E; Scheunemann, M; Steinbach, J | 1 |
| Butler, SG; Cloonan, SM; Corrigan, D; Jørgensen, AM; Keating, JJ; Knox, AJ; Lloyd, DG; Meegan, MJ; Peters, GH; Rai, D; Williams, DC | 1 |
| Butler, SG; Cloonan, SM; Keating, JJ; Knox, AJ; McNamara, YM; Meegan, MJ; Peters, GH; Williams, DC | 1 |
| Levin, JA; Lovenberg, W; Schmidt, CJ | 1 |
| Schmidt, CJ; Taylor, VL | 1 |
| Halme, M; Lauerma, H; Wuorela, M | 1 |
| Butcher, SP; Lawrence, JA; Marston, HM; Olverman, HJ; Reid, ME | 1 |
| Kristensen, AS; Mortensen, OV; Rudnick, G; Wiborg, O | 1 |
| Rink, J; Stein, DJ | 1 |
| McEvoy, C; Neumaier, JF; Sexton, TJ | 1 |
| Baumann, C; Gamma, A; Liechti, ME; Vollenweider, FX | 1 |
| Liechti, ME; Vollenweider, FX | 1 |
| Geyer, MA; Hell, D; Liechti, ME; Vollenweider, FX | 1 |
| Ceglia, I; Gobbi, M; Mennini, T; Moia, M; Pirona, L; Reyes-Parada, M; Scorza, C | 1 |
| Kovar, KA; Lebsanft, HB; Mayerhofer, A; Schmidt, WJ | 1 |
| Adkins, EM; Blakely, RD; Field, JR; Henry, LK; Newman, AH; Parnas, ML; Vaughan, RA; Zou, MF | 1 |
| Bomsien, S; Skopp, G | 1 |
| Ali, SF; Fraiman, JB; Meyer, JS; Owens, CB; Piper, BJ | 1 |
| Fahey, MA; Fryer, AK; Lynch, L; Madras, BK; Miller, GM; Verrico, CD | 1 |
| Allott, K; Broadbear, JH; Canny, BK; Murphy, B; Redman, J; Stepto, NK | 1 |
| El Yacoubi, M; Hamon, M; Hanoun, N; Lanfumey, L; Lesch, KP; Melfort, M; Païzanis, E; Renoir, T; Saurini, F | 1 |
| Adori, C; Andó, RD; Bagdy, G; Ferrington, L; Kelly, PA; Kirilly, E; Kovács, GG; Molnár, E | 1 |
| Kittler, K; Lau, T; Schloss, P | 1 |
| Ali, SF; Daniels, LG; Meyer, JS; Piper, BJ | 1 |
| Drummer, OH; Gerostamoulos, D; Pilgrim, JL | 1 |
| Amos-Kroohs, RM; Braun, AA; Grace, CE; Graham, DL; Schaefer, TL; Skelton, MR; Vorhees, CV; Williams, MT | 1 |
| Hanck, L; Schellekens, AF | 1 |
| Hentschke, H; Liebig, L; von Ameln-Mayerhofer, A | 1 |
| Duffy, P; Gorman, I; Gormley, S; Harkin, A; Jennings-Murphy, C; Kelly, ME; Kerskens, CM; Rouine, J | 1 |
| Chen, LC; Huang, YS; Kao, TJ; Li, IH; Lin, YY; Ma, KH; Weng, SJ; Yen, TY | 1 |
| Islas, ÁA; Scior, T | 1 |
3 trial(s) available for citalopram and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram.
Topics: Adult; Amphetamine-Related Disorders; Brain; Citalopram; Double-Blind Method; Female; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Nootropic Agents; Selective Serotonin Reuptake Inhibitors | 2000 |
The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.
Topics: Adult; Animals; Blood Pressure; Body Temperature; Citalopram; Cross-Over Studies; Dopamine; Double-Blind Method; Female; Hallucinogens; Heart Rate; Humans; Male; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Placebos; Selective Serotonin Reuptake Inhibitors; Serotonin | 2000 |
Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.
Topics: Adult; Affect; Cannabis; Citalopram; Drug Users; Female; Humans; Hydrocortisone; Male; N-Methyl-3,4-methylenedioxyamphetamine; Personality; Prolactin; Selective Serotonin Reuptake Inhibitors; Sex Characteristics | 2009 |
28 other study(ies) available for citalopram and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.
Topics: Animals; Carbon Radioisotopes; Cell Line; Humans; Indoles; Isoquinolines; Isotope Labeling; Ligands; Positron-Emission Tomography; Propylamines; Rats; Rats, Inbred Strains; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship | 2008 |
Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.
Topics: Amphetamines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Phenethylamines; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Sulfur | 2009 |
Synthesis and serotonin transporter activity of 1,3-bis(aryl)-2-nitro-1-propenes as a new class of anticancer agents.
Topics: Alkenes; Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Molecular Structure; Nitro Compounds; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2011 |
In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Citalopram; Corpus Striatum; Dopamine; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism | 1987 |
Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Cerebral Cortex; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Ketanserin; Kinetics; Male; Methiothepin; N-Methyl-3,4-methylenedioxyamphetamine; Piperonyl Butoxide; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tryptophan Hydroxylase | 1987 |
Interaction of serotonin reuptake inhibitor and 3,4-methylenedioxymethamphetamine?
Topics: Citalopram; Drug Interactions; Hallucinogens; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Selective Serotonin Reuptake Inhibitors | 1998 |
Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat.
Topics: Animals; Behavior, Animal; Biogenic Monoamines; Chromatography, High Pressure Liquid; Citalopram; Kinetics; Male; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Radioligand Assay; Rats | 1999 |
Molecular cloning, expression and characterization of a bovine serotonin transporter.
Topics: Amino Acid Sequence; Animals; Carrier Proteins; Cattle; Citalopram; Cloning, Molecular; Desipramine; Female; Fluoxetine; HeLa Cells; Humans; Imipramine; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Sequence Data; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Organ Specificity; Paroxetine; Phylogeny; Pregnancy; Rats; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sequence Alignment; Sequence Homology, Amino Acid; Serotonin; Serotonin Plasma Membrane Transport Proteins; Transfection | 1999 |
Effects of "Ecstasy" blocked by serotonin reuptake inhibitors.
Topics: Adult; Citalopram; Female; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Trichotillomania | 1999 |
(+) 3,4-methylenedioxymethamphetamine ('ecstasy') transiently increases striatal 5-HT1B binding sites without altering 5-HT1B mRNA in rat brain.
Topics: Adrenergic beta-Antagonists; Animals; Brain Chemistry; Citalopram; Corpus Striatum; Dose-Response Relationship, Drug; Gene Expression; Hippocampus; In Situ Hybridization; Iodine Radioisotopes; Iodocyanopindolol; N-Methyl-3,4-methylenedioxyamphetamine; Radioligand Assay; Raphe Nuclei; Rats; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Tritium | 1999 |
Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.
Topics: Acoustic Stimulation; Adult; Citalopram; Dose-Response Relationship, Drug; Double-Blind Method; Female; Habituation, Psychophysiologic; Haloperidol; Humans; Ketanserin; Male; Models, Psychological; N-Methyl-3,4-methylenedioxyamphetamine; Psychiatric Status Rating Scales; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Serotonin | 2001 |
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
Topics: Amphetamines; Animals; Binding, Competitive; Brain Chemistry; Carrier Proteins; Citalopram; Dose-Response Relationship, Drug; Hippocampus; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Nerve Tissue Proteins; p-Chloroamphetamine; Piperazines; Rats; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Tritium | 2002 |
Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Agents; Animals; Apomorphine; Behavior, Animal; Citalopram; Dopamine; Fenclonine; Functional Laterality; Hallucinogens; Male; Medial Forebrain Bundle; Models, Animal; N-Methyl-3,4-methylenedioxyamphetamine; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotation; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2003 |
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
Topics: Adrenergic Uptake Inhibitors; Amino Acid Sequence; Animals; Antidepressive Agents; Binding Sites; Binding, Competitive; Blotting, Western; Cadmium; Cell Line; Cell Membrane; Citalopram; Clomipramine; Cocaine; Cysteine; Dopamine Uptake Inhibitors; Fluoxetine; HeLa Cells; Humans; Immunoprecipitation; Isoleucine; Kinetics; LLC-PK1 Cells; Mazindol; Methionine; Mice; Models, Chemical; Molecular Sequence Data; Mutation; N-Methyl-3,4-methylenedioxyamphetamine; Nomifensine; Protein Binding; Protein Structure, Tertiary; Protein Transport; Radiopharmaceuticals; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Species Specificity; Stereoisomerism; Substrate Specificity; Tyrosine | 2006 |
An in vitro approach to potential methadone metabolic-inhibition interactions.
Topics: Algorithms; Amitriptyline; Analgesics, Opioid; Atomoxetine Hydrochloride; Chromatography, Liquid; Citalopram; Clozapine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Isoenzymes; Kinetics; Methadone; Methylation; N-Methyl-3,4-methylenedioxyamphetamine; Oxidoreductases, N-Demethylating; Propylamines; Psychotropic Drugs; Pyridines; Pyrrolidines; Tandem Mass Spectrometry; Zolpidem | 2007 |
Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Body Weight; Brain Chemistry; Citalopram; Dose-Response Relationship, Drug; Ejaculation; Exploratory Behavior; Hallucinogens; Interpersonal Relations; Male; Maze Learning; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Selective Serotonin Reuptake Inhibitors; Time Factors | 2008 |
MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor.
Topics: Administration, Oral; Animals; Appetitive Behavior; Association Learning; Cell Line; Citalopram; Desipramine; Discrimination Learning; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Injections, Intramuscular; Macaca fascicularis; Male; Mental Recall; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Reversal Learning; Serotonin Plasma Membrane Transport Proteins; Stereotyped Behavior | 2008 |
Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cell Proliferation; Citalopram; Electrophysiology; Female; Hallucinogens; Hindlimb Suspension; Hippocampus; Injections, Intraperitoneal; Male; Membranes; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Patch-Clamp Techniques; Raphe Nuclei; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Swimming | 2008 |
Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion.
Topics: Animals; Anxiety; Axons; Brain; Citalopram; Fluoxetine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neuropsychological Tests; Piperazines; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Social Behavior; Time Factors | 2010 |
Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons.
Topics: Animals; Cell Line; Citalopram; Cocaine; Gene Expression Regulation; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Protein Transport; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2010 |
Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats.
Topics: Age Factors; Animals; Binding, Competitive; Body Temperature; Cerebral Cortex; Citalopram; Dose-Response Relationship, Drug; Drug Administration Schedule; Fever; Hippocampus; Hydroxyindoleacetic Acid; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins | 2010 |
Deaths involving serotonergic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Australia; Cause of Death; Citalopram; Cyclohexanols; Female; Fluoxetine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Serotonin Agents; Sertraline; Tramadol; Venlafaxine Hydrochloride | 2010 |
Cognitive impairments from developmental exposure to serotonergic drugs: citalopram and MDMA.
Topics: Animals; Animals, Newborn; Body Weight; Citalopram; Cognition Disorders; Disease Models, Animal; Female; Locomotion; Male; Maze Learning; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Agents; Swimming | 2013 |
[Hallucinogen persisting perception disorder after ecstasy use].
Topics: Anxiety Disorders; Citalopram; Depressive Disorder; Hallucinations; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2013 |
MDMA modulates spontaneous firing of subthalamic nucleus neurons in vitro.
Topics: Action Potentials; Adrenergic Uptake Inhibitors; Animals; Citalopram; Desipramine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Rats; Rats, Sprague-Dawley; Serotonin Agents; Subthalamic Nucleus | 2015 |
Investigation of the mechanisms mediating MDMA "Ecstasy"-induced increases in cerebro-cortical perfusion determined by btASL MRI.
Topics: Animals; Brain; Cerebrovascular Circulation; Citalopram; Dopamine Antagonists; Fenclonine; Fenfluramine; Magnetic Resonance Imaging; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin Antagonists; Serotonin Receptor Agonists; Spin Labels | 2015 |
Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity.
Topics: Adenine; Animals; Autophagy; Benzylamines; Brain Stem; Cells, Cultured; Citalopram; Dose-Response Relationship, Drug; Down-Regulation; Fluorine Radioisotopes; Functional Neuroimaging; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Neurites; Neuroprotective Agents; Phagosomes; Positron-Emission Tomography; Rats; Serotonergic Neurons; Serotonin Plasma Membrane Transport Proteins | 2016 |
Allosteric Binding of MDMA to the Human Serotonin Transporter (hSERT) via Ensemble Binding Space Analysis with ΔG Calculations, Induced Fit Docking and Monte Carlo Simulations.
Topics: Antidepressive Agents; Citalopram; Humans; Monte Carlo Method; N-Methyl-3,4-methylenedioxyamphetamine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2022 |